Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pharma-Bio Serv (PBSV) Gross Profit (2016 - 2025)

Historic Gross Profit for Pharma-Bio Serv (PBSV) over the last 16 years, with Q4 2025 value amounting to $748935.0.

  • Pharma-Bio Serv's Gross Profit rose 307.82% to $748935.0 in Q4 2025 from the same period last year, while for Oct 2025 it was $2.9 million, marking a year-over-year increase of 1565.93%. This contributed to the annual value of $2.9 million for FY2025, which is 1565.93% up from last year.
  • According to the latest figures from Q4 2025, Pharma-Bio Serv's Gross Profit is $748935.0, which was up 307.82% from $574262.0 recorded in Q3 2025.
  • Pharma-Bio Serv's Gross Profit's 5-year high stood at $1.6 million during Q3 2023, with a 5-year trough of $535609.0 in Q1 2024.
  • Over the past 5 years, Pharma-Bio Serv's median Gross Profit value was $1.2 million (recorded in 2022), while the average stood at $1.0 million.
  • In the last 5 years, Pharma-Bio Serv's Gross Profit plummeted by 5900.77% in 2024 and then skyrocketed by 4340.85% in 2025.
  • Quarter analysis of 5 years shows Pharma-Bio Serv's Gross Profit stood at $1.5 million in 2021, then dropped by 26.04% to $1.1 million in 2022, then fell by 16.13% to $929805.0 in 2023, then decreased by 21.86% to $726570.0 in 2024, then rose by 3.08% to $748935.0 in 2025.
  • Its last three reported values are $748935.0 in Q4 2025, $574262.0 for Q3 2025, and $818726.0 during Q2 2025.